Bas Goulooze
Onderzoeker / gast
- Naam
- Dr. S.C. Goulooze
- Telefoon
- +31 71 527 6329
- s.c.goulooze@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0003-3369-6107
In deze video van Scientist Wanted vertelt Bas Goulooze meer over zijn onderzoek naar effectieve pijnbestrijding na operaties. Scientist Wanted is een platform voor jonge wetenschappers die graag over hun onderzoek vertellen en een brug willen slaan tussen wetenschap en het grote publiek.
Vanwege de gekozen cookie-instellingen kunnen we deze video hier niet tonen.
Bekijk de video op de oorspronkelijke website ofOnderzoeker / gast
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Pharmacology
- Wu Y., Allegaert K., Flint R.B., Goulooze S.C., Valitalo P.A.J., Hoog M. de, Mulla H., Sherwin C.M.T., Simons S.H. P., Krekels E.H.J., Knibbe C.A.J. & Völler S. (2024), When will the glomerular filtration rate in former preterm neonates catch up with their term peers?, Pharmaceutical Research 41(4): 637-649.
- Kanhai K.M.S., Goulooze S.C., Grond J. van der, Harms A.C., Hankemeier T., Verma A., Dent G., Chavez J., Meijering H. & Groeneveld G.J. (2022), Kinetics of myelin breakdown products: a labeling study in patients with progressive multiple sclerosis, Clinical and Translational Science 15(3): 638-648.
- Engbers A.G.J., Völler S., Flint R.B., Goulooze S.C., Klerk J. de, Krekels E.H.J., Dijk M. van, Willemsen S.P., Reiss I.K.M., Knibbe C.A.J. & Simons S.H.P. (2022), The effect of ibuprofen exposure and patient characteristics on the closure of the patent Ductus Arteriosus in preterm infants, Clinical Pharmacology & Therapeutics 112(2): 307-315.
- Goulooze S.C., Krekels E.H.J., Saleh M.A.A.E.W., Ahlers S.J., Valitalo P.A.J., Dongen E.P. van, Schaik R.H. van, Hankemeier T., Tibboel D. & Knibbe C.A.J. (2021), Predicting unacceptable pain in cardiac surgery patients receiving morphine maintenance and rescue doses: a model-based pharmacokinetic-pharmacodynamic analysis, Anesthesia and Analgesia 132(3): 726-734.
- Valkenburg A.J., Goulooze S.C., Breatnach C.V., Mathôt R.A.A., Tibboel D., Dijk M. van, Knibbe C.A.J. & Peeters M.Y.M. (2021), Sedation with midazolam after cardiac surgery in children with and without Down syndrome: a pharmacokinetic-pharmacodynamic study, Pediatric Critical Care Medicine 22(4): e259-e269.
- Smit C., Goulooze S.C., Bruggemann R.J.M., Sherwin C.M. & Knibbe C.A.J. (2021), Dosing recommendations for vancomycin in children and adolescents with varying levels of obesity and renal dysfunction: a population pharmacokinetic study in 1892 children aged 1-18 years, AAPS Journal 23(3): 53.
- Hoogd S. de, Goulooze S.C., Valkenburg A.J., Krekels E.H.J., Dijk M. van, Tibboel D. & Knibbe C.A.J. (2021), Postoperative breakthrough pain in paediatric cardiac surgery not reduced by increased morphine concentrations, Pediatric Research 90: 1201-1206.
- Goulooze S.C., Ista E., Dijk M. van, Tibboel D., Krekels E.H.J. & Knibbe C.A.J. (2021), Towards evidence-based weaning: a mechanism-based pharmacometric model to characterize iatrogenic withdrawal syndrome in critically ill children, AAPS Journal 23(4): 71.
- Upadhyay P., Vet N.J., Goulooze S.C., Krekels E.H.J., Wildt S.N. de & Knibbe C.A.J. (2021), Midazolam infusion and disease severity affect the level of sedation in children: a parametric time-to-event analysis, Pharmaceutical Research 38: 1711-1720.
- Goulooze S.C., Kluis T. de, Dijk M. van, Ceelie I., Wildt S.N. de, Tibboel D., Krekels E.H.J. & Knibbe C.A.J. (2021), Quantifying the pharmacodynamics of morphine in the treatment of postoperative pain in preverbal children, The Journal of Clinical Pharmacology 62(1): 99-109.
- Goulooze S.C., Zwep L.B., Vogt J.E., Krekels E.H.J., Hankemeier T., Anker J.N. van den & Knibbe C.A.J. (2020), Beyond the randomized clinical trial: innovative data science to close the pediatric evidence gap, Clinical Pharmacology & Therapeutics 107(4): 786-795.
- Goulooze S.C. (3 november 2020), Novel pharmacometric techniques to quantify the pharmacodynamics of analgesics: Tools of the trade (Dissertatie. Leiden Academic Centre for Drug Research (LACDR), Faculty of Science, Leiden University). Promotor(en) en copromotor(en): Knibbe C.A.J. & Hankemeier T., Krekels E.H.J.
- Valkenburg A.J., Goulooze S.C., Ng C.Y., Breatnach C.V., Tibboel D., Dijk M. van, Knibbe C.A.J. & Krekels E.H.J. (2020), Exploring the relationship between morphine concentration and oversedation in children after cardiac surgery, The Journal of Clinical Pharmacology 60(9): 1231-1236.
- Goulooze S.C., Kruithof A.C., Alikunju S., Gautam A., Burggraaf J., Kamerling I.M.C. & Stevens J. (2020), The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL-17822 in healthy male volunteers, British Journal of Clinical Pharmacology 86(10): 2095-2101.
- Smit C., Wasmann R.E., Goulooze S.C., Wiezer M.J., Dongen E.P.A. van, Mouton J.W., Brüggemann R.J.M. & Knibbe C.A.J. (2019), Population pharmacokinetics of vancomycin in obesity: finding the optimal dose for (morbidly) obese individuals, British Journal of Clinical Pharmacology 86(2): 303-317.
- Goulooze S.C., Ista E., Dijk M. van, Hankemeier T., Tibboel D., Knibbe C.A.J. & Krekels E.H.J. (2019), Supervised Multidimensional Item Response Theory Modeling of Pediatric Iatrogenic Withdrawal Symptoms, CPT: Pharmacometrics and Systems Pharmacology 8(12): 904-912.
- Smit C., Wasmann R.E., Goulooze S.C., Hazebroek E.J., Dongen E.P.A. van, Burgers D.M.T., Mouton J.W., Brüggemann R.J.M. & Knibbe C.A.J. (2019), A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients, Clinical Pharmacokinetics 58(10): 1333-1343.
- Goulooze S.C., Völler S., Valitalo P.A.J., Calvier E.A.M., Aarons L., Krekels E.H.J. & Knibbe C.A.J. (2019), The Influence of Normalization Weight in Population Pharmacokinetic Covariate Models, Clinical Pharmacokinetics 58(1): 131-138.
- Goulooze S.C., Krekels E.H.J., Hankemeier T. & Knibbe C.A.J. (2019), Covariates in Pharmacometric Repeated Time-to-Event Models: Old and New (Pre)Selection Tools, AAPS Journal 21: 11.
- Goulooze S.C., Välitalo P.A.J., Knibbe C.A.J. & Krekels E.H.J. (2018), Kernel-Based Visual Hazard Comparison (kbVHC): a Simulation-Free Diagnostic for Parametric Repeated Time-to-Event Models, AAPS Journal 20(1): 5.
- Alvarez Jimenez R., Baakman A.C., Stevens J., Goulooze S.C., Hart E.P., Rissmann R., Gerven J.M.A. van & Groeneveld G.J. (2017), Pharmacokinetics and pharmacodynamics of oral mecamylamine – development of a nicotinic acetylcholine receptor antagonist cognitive challenge test using modelling and simulation, Journal of Psychopharmacology 31(2): 192-203.
- Nuchuchua O., Nejadnik M.R., Goulooze S.C., Ljeskovic N.J., Every H.A. & Jiskoot W. (2017), Characterization of drug delivery particles, produced by supercritical carbon dioxide technologies, Journal of Supercritical Fluids 128: 244-262.
- Goulooze S.C., Krekels E.H.J., Dijk M. van, Tibboel D., Graaf P.H. van der, Hankemeier T., Knibbe C.A.J. & Hasselt J.G.C. van (2017), Towards personalized treatment of pain using a quantitative systems pharmacology approach, European Journal of Pharmaceutical Sciences 109: S32-S38.
- Baakman A.C., Alvarez-Jimenez R., Rissmann R., Klaassen E.S., Stevens J., Goulooze S.C., Burger J.C.G. den, Swart E.L., Gerven J.M.A. van & Groeneveld G.J. (2017), An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine, British Journal of Clinical Pharmacology 83(8): 1676-1687.
- Goulooze S.C., Franson K.L., Cohen A.F. & Rissmann R. (2017), Clinical Pharmacology Research Internships at the Interface between Academia and Industry: Students' Perceptions and Scientific Output, Basic & Clinical Pharmacology & Toxicology 121(1): 22-28.
- Kanhai K., Goulooze S.C., Stevens J., Dent G., Verma A., Hankemeier T., Boer T. de, Meijering H., Chavez J. & Groeneveld G.J. (2016), Quantifying myelin kinetics in healthy subjects using deuterium labeling, Clinical Pharmacology & Therapeutics 99: S15-S15.
- Goulooze S.C., Galettis P., Boddy A.V. & Martin J.H. (2016), Monte Carlo simulations of the clinical benefits from therapeutic drug monitoring of sunitinib in patients with gastrointestinal stromal tumours, Cancer Chemotherapy and Pharmacology 78(1): 209-216.
- Alvarez-Jimenez R., Groeneveld G.J., Gerven J.M. van, Goulooze S.C., Baakman A.C., Hay J.L. & Stevens J. (2016), Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjects, British Journal of Clinical Pharmacology 82: 1011-1021.
- Kanhai K.M.S., Goulooze S.C., Stevens J., Hay J.L., Dent G., Verma A., Hankemeier T., Boer T. de, Meijering H., Chavez J.C., Cohen A.F. & Groeneveld G.J. (2016), Quantifying Beta‐Galactosylceramide Kinetics in Cerebrospinal Fluid of Healthy Subjects Using Deuterium Labeling, Clinical and Translational Science 9(6): 321-327.
- Goulooze S.C., Cohen A.F. & Rissmann R. (2016), Olaparib, British Journal of Clinical Pharmacology 81(1): 171-173.
- Goulooze S.C., Cohen A.F. & Rissmann R. (2015), Bedaquiline, British Journal of Clinical Pharmacology 80(2): 182-184.
- Goulooze S.C., Cohen A.F. & Rissmann R. (2015), Mirabegron, British Journal of Clinical Pharmacology 80(4): 762-764.
- Goulooze S.C., Cohen A.F. & Rissmann R. (2015), Lomitapide, British Journal of Clinical Pharmacology 80(2): 179-181.